Patents Assigned to HEALTHCARE SYSTEMS CO., LTD.
  • Publication number: 20230375446
    Abstract: Provided are a reagent, kit, and method for preserving a urine specimen used for analysis of urine components, enabling easy transportation of specimens and acquisition of analysis results equivalent to those of fresh urine even after transportation. A reagent for preserving a urine specimen, comprising a filter paper, wherein the filter paper comprises an aromatic alcohol, a phenol derivative, or a polyhydric fatty alcohol.
    Type: Application
    Filed: November 1, 2021
    Publication date: November 23, 2023
    Applicant: HEALTHCARE SYSTEMS CO., LTD.
    Inventors: Masashi NAGAI, Michiko ITO HAYASHI
  • Patent number: 10538580
    Abstract: An anti-equol antibody composition, containing an anti-equol antibody or antibody fragment thereof containing, as an immunoglobulin heavy chain variable region, hypervariable regions CDR1, CDR2, and CDR3 respectively including amino acid sequences represented by SEQ ID NO: 1-3, and as an immunoglobulin light chain variable region, hypervariable regions CDR1?, CDR2?, and CDR3? respectively including amino acid sequences represented by SEQ ID NO: 4-6; and an anti-equol antibody or antibody fragment thereof containing, as an immunoglobulin heavy chain variable region, hypervariable regions CDR1, CDR2, and CDR3 respectively including amino acid sequences represented by SEQ ID NO: 1-3, and as an immunoglobulin light chain variable region, hypervariable regions CDR1?, CDR2?, and CDR3? respectively including amino acid sequences represented by SEQ ID NO: 7-9.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: January 21, 2020
    Assignee: HEALTHCARE SYSTEMS CO., LTD.
    Inventors: Yosuke Takimoto, Keitaro Hagiwara
  • Publication number: 20190300597
    Abstract: An anti-equol antibody composition, containing an anti-equol antibody or antibody fragment thereof containing, as an immunoglobulin heavy chain variable region, hypervariable regions CDR1, CDR2, and CDR3 respectively including amino acid sequences represented by SEQ ID NO: 1-3, and as an immunoglobulin light chain variable region, hypervariable regions CDR1?, CDR2?, and CDR3? respectively including amino acid sequences represented by SEQ ID NO: 4-6; and an anti-equol antibody or antibody fragment thereof containing, as an immunoglobulin heavy chain variable region, hypervariable regions CDR1, CDR2, and CDR3 respectively including amino acid sequences represented by SEQ ID NO: 1-3, and as an immunoglobulin light chain variable region, hypervariable regions CDR1?, CDR2?, and CDR3? respectively including amino acid sequences represented by SEQ ID NO: 7-9.
    Type: Application
    Filed: December 18, 2017
    Publication date: October 3, 2019
    Applicant: HEALTHCARE SYSTEMS CO., LTD.
    Inventors: Yosuke TAKIMOTO, Keitaro HAGIWARA